Bidirectional effects of opioids in motivational processes and the involvement of D1 dopamine receptors
- PMID: 2855853
Bidirectional effects of opioids in motivational processes and the involvement of D1 dopamine receptors
Abstract
Exogenous and endogenous opioids significantly affect motivational processes; depending on the particular opioid receptor type with which they interact opposite effects are induced: activation of mu and delta opioid receptors is rewarding whereas activation of kappa opioid receptors induces aversive effects. Antagonism of mu-opioid receptors also induces aversion, suggesting the existence of a tonically active opioidergic reward pathway. There is evidence that beta-endorphin pathways arising from the hypothalamus play an important role in this respect. Opioid-induced reward as well as aversion seem to be mediated by the mesolimbic dopamine system, reward by increased, aversion by decreased transmission at D1 dopamine receptors.
Similar articles
-
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.J Pharmacol Exp Ther. 1993 Apr;265(1):53-9. J Pharmacol Exp Ther. 1993. PMID: 8386244
-
[Opiate addiction. Pharmacologic and biochemical aspects].Arzneimittelforschung. 1992 Feb;42(2A):256-9. Arzneimittelforschung. 1992. PMID: 1586396 Review. German.
-
[Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants].Nervenarzt. 1995 Jan;66(1):3-14. Nervenarzt. 1995. PMID: 7885510 Review. German.
-
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.J Pharmacol Exp Ther. 1993 Jan;264(1):489-95. J Pharmacol Exp Ther. 1993. PMID: 8093731
-
Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.J Pharmacol Exp Ther. 1993 Oct;267(1):205-10. J Pharmacol Exp Ther. 1993. PMID: 8229747
Cited by
-
The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.Neuropharmacology. 2019 Nov 1;158:107597. doi: 10.1016/j.neuropharm.2019.04.003. Epub 2019 Apr 8. Neuropharmacology. 2019. PMID: 30974107 Free PMC article.
-
Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.Can J Vet Res. 1993 Apr;57(2):106-9. Can J Vet Res. 1993. PMID: 8490803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials